Pathogen-specific antigen presentation

Pathogen-specific antigen presentation is the process by which cells degrade pathogen-derived proteins into peptide fragments, load them onto MHC molecules (class I or II), and display them on the cell surface for recognition by T cells. This is essential for initiating adaptive immune responses against infections and tumors, and for maintaining immune tolerance. Key molecular players include antigen-presenting cells (dendritic cells, macrophages, B cells), MHC class I and II molecules, the proteasome, transporter associated with antigen processing (TAP), and various chaperone proteins. The process is critical in many diseases but refers to a pathway, not a discrete druggable target. "Pathogen-specific antigen presentation" is a multi-component immune process, not a molecular target, receptor, or druggable entity. Any structured information system should instead reference specific molecules within the pathway (e.g., "Major histocompatibility complex class I molecule", "TAP transporter", "Proteasome"), as these may be true therapeutic targets. Listing the process as a stand-alone drug target is incorrect and should be revised for accurate biomedical ontology and drug discovery mapping.

Other names

Antigen presentationMHC-mediated antigen displayAntigen processing and presentation

Not applicable